Texas A&M signed the nation’s top-ranked class three years ago believing it had built a potential national title contender. Plenty of players from that heralded 2022 class could indeed be ...
BioInvent is in a pivotal stage of development with upcoming important data readouts from three of its six antibody programs around year-end 2024, and an additional seven major data readouts expected ...